Literature DB >> 11797996

Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation.

R Willems1, K R Sipido, P Holemans, H Ector, F Van de Werf, H Heidbüchel.   

Abstract

INTRODUCTION: It is well established that rapid atrial rates, as in atrial fibrillation (AF), cause atrial electrical and structural remodeling leading to the maintenance of AF. The role of neurohumoral changes in this pathophysiologic vicious circle remains unclear. METHODS AND
RESULTS: We followed the concentrations of angiotensin II (AT II) and atrial natriuretic peptide (ANP) in a sheep model of AF. The sheep were atrially paced at 600 beats/min for 15 weeks. Electrophysiologic study was performed at regular intervals, and venous blood samples were taken. There was a slow increase in the vulnerability for AF. The cumulative incidence of sustained AF was 80% after 15 weeks of pacing. This increased vulnerability for AF was accompanied by atrial electrical remodeling and an increase in atrial pressure. AT II increased rapidly and stayed elevated: 17+/-4 pg/mL at baseline, and 40+/-11 and 39+/-7 pg/mL after 1 and 12 weeks of pacing, respectively. ANP rose more progressively: 35+/-7 pg/mL at baseline, and 72+/-17, 95+/-10, and 106+/-23 pg/mL after 1, 3, and 12 weeks, respectively. ANP levels correlated with atrial pressure and inducibility of AF. There was no relation between these parameters and AT II levels.
CONCLUSION: AT II and ANP increased significantly in this animal model of AF. Elevation of AT II occurs early and seems to be dependent on rapid atrial rate rather than the presence of AF. ANP increased more progressively. It paralleled the inducibility of AF and atrial stretch. Both neurohumoral pathways may form a potential therapeutic target for treatment of patients with AF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797996     DOI: 10.1046/j.1540-8167.2001.01387.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics.

Authors:  W Anné; R Willems; N Van der Merwe; F Van de Werf; H Ector; H Heidbüchel
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.

Authors:  Rafik R Anis
Journal:  Exp Clin Cardiol       Date:  2009

3.  Effects of low-dose amiodarone and Betaloc on the treatment of hypertrophic cardiomyopathy complicated with malignant ventricular arrhythmias.

Authors:  Yu Gao; Peisheng Zhang; Xue Liang
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

4.  Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.

Authors:  Xuewen Wang; Guangping Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jan-Mar       Impact factor: 1.636

Review 5.  Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

Authors:  Nathan C Denham; Charles M Pearman; Jessica L Caldwell; George W P Madders; David A Eisner; Andrew W Trafford; Katharine M Dibb
Journal:  Front Physiol       Date:  2018-10-04       Impact factor: 4.566

6.  Optimising Large Animal Models of Sustained Atrial Fibrillation: Relevance of the Critical Mass Hypothesis.

Authors:  Nathan C Denham; Charles M Pearman; George W P Madders; Charlotte E R Smith; Andrew W Trafford; Katharine M Dibb
Journal:  Front Physiol       Date:  2021-06-15       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.